Clinical Effects of Activated Charcoal Unavailability on Treatment Outcomes for Oral Drug Poisoned Patients

Table 3

Charcoal availability and clinical outcome.

	Charcoal-available period	Charcoal-unavailable period	p-value
Aspiration pneumonia, n (%)	41 (9.9%)	21 (9.5%)	0.864
Endotracheal intubation, n (%)	35 (8.5%)	16 (7.2%)	0.586
Vasopressor, n (%)	22 (5.3%)	11 (5.0%)	0.850
Mortality, n (%)	8 (1.9%)	2 (0.9%)	0.507
Hospital admission, n (%)	179 (43.3%)	66 (29.9%)	<0.001
ICU admission, n (%)	24 (5.8%)	30 (13.6%)	<0.001

ICU: intensive care unit.